17 Citations (SciVal)

Abstract

The identification and detection of disease-related biomarkers is essential for early clinical diagnosis, evaluating disease progression, and for the development of therapeutics. Possessing the advantages of high sensitivity and selectivity, fluorescent probes have become effective tools for monitoring disease-related active molecules at the cellular level and in vivo. In this review, we describe current fluorescent probes designed for the detection and quantification of key bioactive molecules associated with common diseases, such as organ damage, inflammation, cancers, cardiovascular diseases, and brain disorders. We emphasize the strategies behind the design of fluorescent probes capable of disease biomarker detection and diagnosis and cover some aspects of combined diagnostic/therapeutic strategies based on regulating disease-related molecules. This review concludes with a discussion of the challenges and outlook for fluorescent probes, highlighting future avenues of research that should enable these probes to achieve accurate detection and identification of disease-related biomarkers for biomedical research and clinical applications.
Original languageEnglish
Pages (from-to)7106-7164
Number of pages59
JournalChemical Reviews
Volume124
Issue number11
Early online date17 May 2024
DOIs
Publication statusPublished - 12 Jun 2024

Funding

This work was supported by the National Natural Science Foundation of China (22134004, 22074083, 22377070, 22304107, 21927811), the Key Research and Development Program of Shandong Province (2018YFJH0502), and the National Science Foundation of Shandong Province of China (ZR2020ZD17, ZR2023YQ016, ZR2021QB042). T.D.J. thanks the Open Research Fund of the School of Chemistry and Chemical Engineering, Henan Normal University (2020ZD01), for support. S.E.L., T.D.J., and L.W. thank the University of Bath and EPSRC (EP/W036193/1) for support. T.G., E.M.S, and O.K. thanks the Science Foundation Ireland (SFI) funded, Synthesis and Solid-State Pharmaceutical Centre (SSPC) (Research Centres Phase 2:12/RC/2275_P2), and the Advanced Materials and Bioengineering Research (AMBER) (Research Centres Phase 2:12/RC/2278_P2) for funding support.

FundersFunder number
Science Foundation Ireland
University of Bath
Advanced Materials and Bioengineering Research2:12/RC/2278_P2
Advanced Materials and Bioengineering Research
Synthesis and Solid State Pharmaceutical Centre2:12/RC/2275_P2
Synthesis and Solid State Pharmaceutical Centre
Engineering and Physical Sciences Research CouncilEP/W036193/1
Engineering and Physical Sciences Research Council
Henan Normal University2020ZD01
Henan Normal University
National Natural Science Foundation of China21927811, 22134004, 22074083, 22304107, 22377070
National Natural Science Foundation of China
Key Technology Research and Development Program of Shandong Province2018YFJH0502
Key Technology Research and Development Program of Shandong Province
National Science Foundation of Shandong Province of ChinaZR2021QB042, ZR2020ZD17, ZR2023YQ016

Fingerprint

Dive into the research topics of 'Fluorescent Probes for Disease Diagnosis'. Together they form a unique fingerprint.

Cite this